DGX - Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients.
As of Jun 30, 2026: spot at $212.38, ATM IV 22.9%, max pain $190.00, net GEX $3.6M.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Market Cap
- $23.23B
- P/E Ratio
- 22.55
- Beta
- 0.59
- 52-Week Range
- 164.65-213.5
- Dividend Yield
- $3.26
- CEO
- James E. Davis
- Employees
- 55,000
- IPO Date
- Dec 17, 1996
- Exchange
- NYSE
What DGX Looks Like to Options Traders Today
IV rank of 34.3% sits near the 1-year median, where strategy choice depends on directional conviction and the event calendar rather than vol regime alone; positive net gamma exposure ($3.6M) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.013) is roughly flat across the wings.
What This Page Covers
The DGX overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked DGX overview questions
- What is DGX?
- DGX is the ticker symbol for Quest Diagnostics Incorporated, a listed security. Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. Listed on NYSE. DGX is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the DGX options snapshot look like today?
- As of Jun 30, 2026, the DGX options snapshot shows spot at $212.38, ATM IV 22.9%, IV rank 34.3%, max pain $190.00, net GEX $3.6M, expected move 6.57%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are DGX's key statistics?
- Quest Diagnostics Incorporated (DGX) carries a market capitalization of $23.23B, trailing P/E ratio of 22.55, beta of 0.59 relative to the broader market, 52-week range of 164.65-213.5. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does DGX belong to?
- Quest Diagnostics Incorporated operates in the Healthcare sector, in the Medical - Diagnostics & Research industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare DGX's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the DGX data on this page?
- The options snapshot above is dated Jun 30, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).